Mouse vaccination with dendritic cells loaded with prion protein peptides overcomes tolerance and delays scrapie

Journal of General Virology

Volumn 91, Issue 3, 2010, Pages 809-820

  Bachy, Véronique ^a,c   Ballerini, Clara ^a,d   Gourdain, Pauline ^a   Prignon, Aurélie ^a   Iken, Saci ^a   Antoine, Nadine ^b   Rosset, Martine ^a   Carnaud, Claude ^a  

^a CENTRE DE RECHERCHE SAINT ANTOINE   (France)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c GUY S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DENDRITIC CELL VACCINE; LYMPHOKINE; PEPTIDE DERIVATIVE; PRION PROTEIN; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFICACY; FEMALE; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; SCRAPIE; SURVIVAL TIME; T LYMPHOCYTE; VACCINATION; WILD TYPE;

ANIMALS; ANTIBODIES; CELL TRANSPLANTATION; CYTOKINES; DENDRITIC CELLS; FEMALE; IMMUNE TOLERANCE; MICE; PEPTIDES; PRIONS; SCRAPIE; SURVIVAL ANALYSIS; T-LYMPHOCYTES;

MAMMALIA; MUS;

EID: 76849115603     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.013417-0     Document Type: Article

References (46)

1. Aucouturier, P., Geissmann, F., Damotte, D., Saborio, G. P., Meeker, H. C., Kascsak, R., Carp, R. I. & Wisniewski, T. (2001). Infected splenic dendritic cells are sufficient for prion transmission to the CNS in mouse scrapie. J Clin Invest 108, 703-708.
2. Bade, S., Baier, M., Boetel, T. & Frey, A. (2006). Intranasal immunization of Balb/c mice against prion protein attenuates orally acquired transmissible spongiform encephalopathy. Vaccine 24, 1242-1253.
3. Ballerini, C., Gourdain, P., Bachy, V., Blanchard, N., Levavasseur, E., Gregoire, S., Fontes, P., Aucouturier, P., Hivroz, C. & Carnaud, C. (2006). Functional implication of cellular prion protein in antigen-driven interactions between T cells and dendritic cells. J Immunol 176, 7254-7262.
4. Bergtold, A., Desai, D. D., Gavhane, A. & Clynes, R. (2005). Cell surface recycling of internalized antigen permits dendritic cell priming of B cells. Immunity 23, 503-514.
5. Boscardin, S. B., Hafalla, J. C., Masilamani, R. F., Kamphorst, A. O., Zebroski, H. A., Rai, U., Morrot, A., Zavala, F., Steinman, R. M. & other authors (2006). Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses. J Exp Med 203, 599-606.
6. Brown, K. L., Stewart, K., Ritchie, D. L., Mabbott, N. A., Williams, A., Fraser, H., Morrison, W. I. & Bruce, M. E. (1999). Scrapie replication in lymphoid tissues depends on prion protein-expressing follicular dendritic cells. Nat Med 5, 1308-1312.
7. Bueler, H., Fischer, M., Lang, Y., Bluethmann, H., Lipp, H. P., DeArmond, S. J., Prusiner, S. B., Aguet, M. & Weissmann, C. (1992). Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356, 577-582.
8. + T cell immunity to mouse survivin. J Immunol 177, 8410-8421.
9. Cormont, F., Manouvriez, P., De Clercq, L. & Bazin, H. (1986). The use of rat monoclonal antibodies to characterize, quantify, and purify polyclonal or monoclonal mouse IgM. Methods Enzymol 121, 622-631.
10. Donne, D. G., Viles, J. H., Groth, D., Mehlhorn, I., James, T. L., Cohen, F. E., Prusiner, S. B., Wright, P. E. & Dyson, H. J. (1997). Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. Proc Natl Acad Sci U S A 94, 13452-13457.
11. Fay, J. W., Palucka, A. K., Paczesny, S., Dhodapkar, M., Johnston, D. A., Burkeholder, S., Ueno, H. & Banchereau, J. (2006). Long-term outcomes in patients with metastatic melanoma vaccinated with melanoma peptide-pulsed CD34(+) progenitor-derived dendritic cells. Cancer Immunol Immunother 55, 1209-1218.
12. Fernandez-Borges, N., Brun, A., Whitton, J. L., Parra, B., Diaz-San Segundo, F., Salguero, F. J., Torres, J. M. & Rodriguez, F. (2006). DNA vaccination can break immunological tolerance to PrP in wild-type mice and attenuates prion disease after intracerebral challenge. J Virol 80, 9970-9976.
13. Glatzel, M. & Aguzzi, A. (2000). PrP(C) expression in the peripheral nervous system is a determinant of prion neuroinvasion. J Gen Virol 81, 2813-2821.
14. Goni, F., Prelli, F., Schreiber, F., Scholtzova, H., Chung, E., Kascsak, R., Brown, D. R., Sigurdsson, E. M., Chabalgoity, J. A. & Wisniewski, T. (2008). High titers of mucosal and systemic anti-PrP antibodies abrogate oral prion infection in mucosal-vaccinated mice. Neuroscience 153, 679-686.
15. Gregoire, S., Logre, C., Metharom, P., Loing, E., Chomilier, J., Rosset, M. B., Aucouturier, P. & Carnaud, C. (2004). Identification of two immunogenic domains of the prion protein - PrP - which activate class II-restricted T cells and elicit antibody responses against the native molecule. J Leukoc Biol 76, 125-134.
16. Gregoire, S., Bergot, A. S., Feraudet, C., Carnaud, C., Aucouturier, P. & Rosset, M. B. (2005). The murine B cell repertoire is severely selected against endogenous cellular prion protein. J Immunol 175, 6443-6449.
17. Gruber, A., Chalmers, A. S., Rasmussen, R. A., Ong, H., Popov, S., Andersen, J., Hu, S. L. & Ruprecht, R. M. (2007). Dendritic cell-based vaccine strategy against human immunodeficiency virus clade C: skewing the immune response toward a helper T cell type 2 profile. Viral Immunol 20, 160-169.
18. Heikenwalder,M., Polymenidou, M., Junt, T., Sigurdson, C., Wagner, H., Akira, S., Zinkernagel, R. & Aguzzi, A. (2004). Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration. Nat Med 10, 187-192.
19. Heppner, F. L.,Musahl, C., Arrighi, I., Klein,M. A., Rulicke, T., Oesch, B., Zinkernagel, R. M., Kalinke, U. & Aguzzi, A. (2001). Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies. Science 294, 178-182.
20. Herrera, O. B., Golshayan, D., Tibbott, R., Salcido Ochoa, F., James, M. J., Marelli-Berg, F. M. & Lechler, R. I. (2004). A novel pathway of alloantigen presentation by dendritic cells. J Immunol 173, 4828-4837.
21. Levavasseur, E., Metharom, P., Dorban, G., Nakano, H., Kakiuchi, T., Carnaud, C., Sarradin, P. & Aucouturier, P. (2007). Experimental scrapie in 'plt' mice: an assessment of the role of dendritic-cell migration in the pathogenesis of prion diseases. J Gen Virol 88, 2353-2360.
22. Lu, W., Wu, X., Lu, Y., Guo, W. & Andrieu, J. M. (2003). Therapeutic dendritic-cell vaccine for simian AIDS. Nat Med 9, 27-32.
23. Mabbott, N. A., Mackay, F., Minns, F. & Bruce, M. E. (2000). Temporary inactivation of follicular dendritic cells delays neuroinvasion of scrapie. Nat Med 6, 719-720.
24. Matzinger, P. (1998). An innate sense of danger. Semin Immunol 10, 399-415.
25. Montrasio, F., Frigg, R., Glatzel, M., Klein, M. A., Mackay, F., Aguzzi, A. & Weissmann, C. (2000). Impaired prion replication in spleens of mice lacking functional follicular dendritic cells. Science 288, 1257-1259.
26. Nair, S. K., Heiser, A., Boczkowski, D., Majumdar, A., Naoe, M., Lebkowski, J. S., Vieweg, J. & Gilboa, E. (2000). Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells. Nat Med 6, 1011-1017.
27. Nestle, F. O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., Burg, G. & Schadendorf, D. (1998). Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med 4, 328-332.
28. Nikles, D., Bach, P., Boller, K., Merten, C. A., Montrasio, F., Heppner, F. L., Aguzzi, A., Cichutek, K., Kalinke, U. & Buchholz, C. J. (2005). Circumventing tolerance to the prion protein (PrP): vaccination with PrP-displaying retrovirus particles induces humoral immune responses against the native form of cellular PrP. J Virol 79, 4033-4042.
29. + T cells in patients with metastatic melanoma vaccinated with antigen-pulsed dendritic cells. J Clin Immunol 25, 288-295.
30. + T-cell immunity. J Immunother 29, 545-557.
31. Polymenidou, M., Heppner, F. L., Pellicioli, E. C., Urich, E., Miele, G., Braun, N., Wopfner, F., Schatzl, H. M., Becher, B. & Aguzzi, A. (2004). Humoral immune response to native eukaryotic prion protein correlates with anti-prion protection. Proc Natl Acad Sci U S A 101 (Suppl. 2), 14670-14676.
32. Prusiner, S. B., Scott, M. R., DeArmond, S. J. & Cohen, F. E. (1998). Prion protein biology. Cell 93, 337-348.
33. Qi, H., Egen, J. G., Huang, A. Y. & Germain, R. N. (2006). Extrafollicular activation of lymph node B cells by antigen-bearing dendritic cells. Science 312, 1672-1676.
34. Rosset, M. B., Ballerini, C., Gregoire, S., Metharom, P., Carnaud, C. & Aucouturier, P. (2004). Breaking immune tolerance to the prion protein using prion protein peptides plus oligodeoxynucleotide-CpG in mice. J Immunol 172, 5168-5174.
35. Rosset, M. B., Sacquin, A., Lecollinet, S., Chaigneau, T., Adam, M., Crespeau, F. & Eloit, M. (2009). Dendritic cell-mediated-immunization with xenogenic PrP and adenoviral vectors breaks tolerance and prolongs mice survival against experimental scrapie. PLoS One 4, e4917.
36. Sacquin, A., Bergot, A. S., Aucouturier, P. & Bruley-Rosset, M. (2008). Contribution of antibody and T cell-specific responses to the progression of 139A-scrapie in C57BL/6 mice immunized with prion protein peptides. J Immunol 181, 768-775.
37. Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K. & other authors (1999). Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400, 173-177.
38. Schwarz, A., Kratke, O., Burwinkel, M., Riemer, C., Schultz, J., Henklein, P., Bamme, T. & Baier, M. (2003). Immunisation with a synthetic prion protein-derived peptide prolongs survival times of mice orally exposed to the scrapie agent. Neurosci Lett 350, 187-189.
39. Sigurdsson, E.M., Brown, D. R., Daniels, M., Kascsak, R. J., Kascsak, R., Carp, R., Meeker, H. C., Frangione, B. & Wisniewski, T. (2002). Immunization delays the onset of prion disease inmice. Am J Pathol 161, 13-17.
40. Sigurdsson, E. M., Sy, M. S., Li, R., Scholtzova, H., Kascsak, R. J., Kascsak, R., Carp, R., Meeker, H. C., Frangione, B. & Wisniewski, T. (2003). Anti-prion antibodies for prophylaxis following prion exposure in mice. Neurosci Lett 336, 185-187.
41. Weigel, B. J., Nath, N., Taylor, P. A., Panoskaltsis-Mortari, A., Chen, W., Krieg, A. M., Brasel, K. & Blazar, B. R. (2002). Comparative analysis of murine marrow-derived dendritic cells generated by Flt3L or GM-CSF/IL-4 and matured with immune stimulatory agents on the in vivo induction of anti-leukemia responses. Blood 100, 4169-4176.
42. White, A. R., Enever, P., Tayebi, M., Mushens, R., Linehan, J., Brandner, S., Anstee, D., Collinge, J. & Hawke, S. (2003). Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature 422, 80-83.
43. Wierecky, J., Müller, M. R., Wirths, S., Halder-Oehler, E., Dörfel, D., Schmidt, S. M., Häntschel, M., Brugger, W., Schröder, S. & other authors (2006). Immunologic and clinical responses after vaccinations with peptide-pulsed dendritic cells in metastatic renal cancer patients. Cancer Res 66, 5910-5918.
44. Wisniewski, T., Aucouturier, P., Soto, C. & Frangione, B. (1998). The prionoses and other conformational disorders. Amyloid 5, 212-224.
45. Wykes, M., Pombo, A., Jenkins, C. & MacPherson, G. G. (1998). Dendritic cells interact directly with naive B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response. J Immunol 161, 1313-1319.
46. Yu, J. S., Liu, G., Ying, H., Yong, W. H., Black, K. L. & Wheeler, C. J. (2004). Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma. Cancer Res 64, 4973-4979.